Device Trial Radar · NCT05457036
Evaluation of the Effect of Spry Belt Treatment on Bone Turnover Marker Profile
Last checked: Nov 20, 2026Latest source record: Aug 29, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
94
Actual
Start
Sep 1, 2022
Primary completion
Oct 31, 2023
Study completion Dec 10, 2023
Sponsor
- Lead sponsor
- Bone Health Technologies, Inc.Not on our public-company list
- Sponsor type
- Industry
- Collaborators
- University of Nebraska; University of California, San Francisco; National Institute on Aging (NIA)
- First posted
- Jul 13, 2022
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, care provider)
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- Female only, from 50 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To conduct a sham-controlled study to rigorously evaluate the effect of Spry Belt treatment on key bone turnover markers (BTMs) over a 12-week period. The investigators will calculate the percentage and absolute changes from baseline for several BTMs for both the active and sham treatment groups.
Conditions
- Osteopenia
- Low Bone Density
Interventions
Spry BeltDevice
The Spry Belt is a device worn around the hips which delivers gentle energy to the lower back. The level of energy is controlled by an internal microprocessor (computer) so that it is safe and comfortable. The energy is at a level that may or may not be perceptible to the user. The device is powered by an internal lithium-ion battery which must be recharged periodically. The device is designed to be used with its companion Spry app (via Bluetooth Low Energy (BLE)) so that anonymous usage statistics may be monitored. The expected shelf life of the device is longer than 2 years and the expected use life is at least 12-18 months.
Sham Spry BeltDevice
The Sham Spry Belt is a device worn around the hips which does not deliver gentle energy to the lower back. The device instead provides a clicking noise similar to a motor. The device is powered by an internal lithium-ion battery which must be recharged periodically. The device is designed to be used with its companion Spry app (via BLE) so that anonymous usage statistics may be monitored. The expected shelf life of the device is longer than 2 years and the expected use life is at least 12-18 months.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change from baseline for Urinary N-telopeptide (uNTX)Time frame: 6 weeks
1 more outcomes with a free account
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Northern California Institute for Research and Education (NCIRE)
San Francisco, California
1 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.